Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,569 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01511393Enrolling by invitation
Tracking people with thyroid cancer to learn its course
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
Morgantown, West VirginiaAges 18 years+ - NCT00583817Enrolling by invitation
Endovascular repair for thoracic aortic aneurysms and dissections
This study tests whether repairing an enlarged or tearing (dissection) thoracic aorta using a catheter-based procedure can be safer for people who are high-risk for open surgery. It uses specialized stent grafts placed through blood vessels to seal the problem and prevent complications.
Boston, MassachusettsAges 18 years+ - NCT01881503Enrolling by invitation
Hemopure for life-threatening anemia when blood transfusions aren’t an option
This study offers HBOC-201 (Hemopure), a type of blood substitute made from bovine (beef) hemoglobin, to treat severe, life-threatening anemia. It’s meant for adults who have very low hemoglobin with serious signs of poor oxygen delivery, and who can’t (or don’t qualify) for standard blood transfusions.
Englewood, New JerseyAges 18–80 - NCT01374984Enrolling by invitation
Test VIGIV treatment for serious complications from smallpox vaccination
This trial looks at how well a medicine called VIGIV works for people who develop serious or unusual vaccinia (smallpox-type) infections or complications after smallpox vaccination. It is mainly for specific skin and body-area problems, including eczema-related complications.
Ages Any age - NCT01205815Recruiting
Use and storage of leftover melanoma tissue for future testing
This study collects and stores leftover melanoma tissue (and sometimes blood) for future research and testing. If the trial uses your stored samples to help match treatments, it could support better care planning over time.
Nashville, TennesseeAges 18 years+ - NCT00068003Enrolling by invitation
Harvesting Cancer Cells for Experimental Treatment
This trial collects immune cells from cancer patients or healthy volunteers to develop new experimental cancer treatments. Researchers will take a sample of your tumor or blood cells, grow them in the lab, and study how to use them to fight your cancer.
Bethesda, MarylandAges 18 years+ - NCT02040714Enrolling by invitation
Study of current treatments for Perthes hip disease
This study follows children (and teens) with Legg-Calvé-Perthes disease to learn about how today’s treatments work in real life. It may help doctors choose the best next steps for your child’s hip health.
Birmingham, AlabamaAges 1–18 - NCT07398326RecruitingPhase 2
Drug combo for advanced colorectal cancer that hasn't spread to the liver
This trial tests a combination of two drugs (anlotinib and sintilimab) as a first treatment for people with advanced colorectal cancer that has spread to places other than the liver, who do not want chemotherapy. The goal is to see if this targeted therapy can help control the cancer.
ShanghaiAges 18 years+ - NCT07398677Recruiting
SchoolCare: Helping kids with cancer stay connected to school
This study tests if a telepresence robot and a school navigator can help children with cancer stay engaged with their school during long treatments. It aims to reduce school disruption and social isolation.
AalborgAges 5–17 - NCT07398807RecruitingEarly Phase 1
Microneedling with chemo cream vs steroid cream for limited vitiligo
This study tests whether microneedling (tiny needles that prick the skin) combined with a chemotherapy cream (5-fluorouracil) works better than a strong steroid cream for treating vitiligo patches on a small area of the body. It's for people with limited vitiligo (covering no more than 10% of their body) who have not used other vitiligo treatments.
Chak Four Hundred Fifty-fourAges 4–70 - NCT07399028Recruiting
Skin changes from biostimulator treatment in women
This study looks at how a biostimulator (a type of injectable treatment that helps your skin produce more collagen) changes your skin. Researchers will use special cameras and scans to see these changes, which may help reduce wrinkles on your cheeks.
New York, New YorkAges 45–65 - NCT07399977Recruiting
Blood test to guide blood thinner use in cancer
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Basking Ridge, New JerseyAges 18 years+ - NCT07400757Recruiting
Statin and vitamin D for active thyroid eye disease
This trial tests whether a statin (a cholesterol-lowering medicine) combined with vitamin D can improve active thyroid eye disease. It may help if you have both eye inflammation and high cholesterol.
Taipei, TaiwanAges 20 years+ - NCT07400783Recruiting
Study of short bowel syndrome in children
This study looks at short bowel syndrome in children who have had intestinal surgery. It may help doctors understand how to better treat this condition.
Florence, FlorenceAges 4 months–17 years - NCT07400809Recruiting
Cervical cancer with limited spread: a study on treatment results
This study looks at women with cervical cancer that has spread to only a few places (oligo-metastatic) or come back in a few places (oligo-recurrent). It hopes to understand how well treating those spots with radiation or other local treatments works, even if you've already had treatment before.
Mumbai, MaharashtraAges Any age - NCT07401524RecruitingPhase 4
Carbetocin to prevent bleeding after twin delivery
This trial tests whether a medication called carbetocin can help prevent heavy bleeding after giving birth to twins. If you are pregnant with twins and at least 23 weeks along, you may be able to join.
Ramat GanAges 18 years+ - NCT07402031Recruiting
Predicting weight loss from obesity treatments
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
Brussels, Brussels CapitalAges 18–65 - NCT07402512RecruitingPhase 3
Study of deuremidevir for RSV in infants and young children
This trial is testing a new medicine called deuremidevir for babies and young children with RSV infection. It is for those who have symptoms like fast breathing and wheezing, and have been sick for no more than 96 hours.
Xiamen, FujianAges 1 month–3 years - NCT07403266RecruitingPhase 3
Full-spectrum cannabis oil for seizures in tuberous sclerosis
This trial tests a full-spectrum cannabis extract to see if it reduces seizures in people with tuberous sclerosis complex (TSC) whose seizures have not been controlled by other treatments. If it works, it could offer a new option for managing hard-to-treat epilepsy.
MadridAges 2–65 - NCT07404085Recruiting
Cognitive training with medication for mood disorders
This trial tests if a medication can boost the effects of cognitive training in people with bipolar disorder or recurrent depression who have memory or thinking problems. It aims to improve daily functioning.
Frederiksberg, Capital Region of DenmarkAges 40–75 - NCT07404397RecruitingPhase 2/Phase 3
Treatments for chronic pelvic pain with high muscle tone
This study compares two treatments for chronic pelvic pain caused by tight pelvic floor muscles: a daily muscle relaxant pill (cyclobenzaprine) or a vibrating massage wand. The goal is to see which works better alongside pelvic floor physical therapy.
Ann Arbor, MichiganAges 18–65 - NCT07404969Recruiting
Integrative medicine for unexplained infertility after treatment
This trial studies whether combining traditional Chinese medicine with standard care can help women with unexplained infertility after previous treatments. It looks at aging markers in your blood to see if they affect your chances of getting pregnant.
NeuchâtelAges 25–42 - NCT07405086RecruitingPhase 4
Morning vs. afternoon immunotherapy for advanced solid tumors
This trial compares giving immunotherapy in the morning versus the afternoon to see if timing affects how well it works. It is for people with certain types of advanced or metastatic solid tumors who have not had this treatment before.
Portland, OregonAges 18 years+ - NCT07405242Recruiting
Treatment for retrograde aortic dissection with a stent graft
This trial tests a stent-graft procedure for a specific type of aortic dissection where the tear starts in the arch or descending aorta and extends backward into the ascending aorta. It is for patients who are not good candidates for open surgery.
Shanghai, Shanghai MunicipalityAges 65 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,569 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.